Germany, June 1 -- Germany based acis Arzneimittel GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient hydrocortisone excl Dafo TAB ATC H02AB09 fdZ 011025-300927 plus extension option 1x12 months . The value of the contract is not disclosed .
Published by HT Digital Content Services with permission from Pivotal Sources....